v3.26.1
SHARE-BASED COMPENSATION - Schedule of Share-based Compensation, Restricted Stock, Restricted Stock Units Activity and SAR's (Details) - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Total share-based compensation expense $ 3,648 $ 2,832
Total share-based compensation expense, amount capitalized $ 140 230
Equity Option    
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]    
Nonvested, weighted average grant date fair value, beginning of period (in dollars per share) $ 2.50  
Nonvested, weighted average grant date fair value, end of period (in dollars per share) $ 5.00  
Employee Stock Option    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Total share-based compensation expense $ 1,260 818
Restricted Stock Units (RSUs)    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Total share-based compensation expense $ 2,388 2,007
Restricted Stock Units (RSUs) | Equity Option    
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested, Number of Shares [Roll Forward]    
Number of nonvested shares, beginning of period (in shares) 1,861,338  
Granted, nonvested, number of shares (in shares) 350,095  
Vested, number of shares (in shares) (883,407)  
Forfeited, number of shares (in shares) (121,626)  
Number of nonvested shares, end of period (in shares) 1,206,400  
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]    
Nonvested, weighted average grant date fair value, beginning of period (in dollars per share) $ 6.22  
Granted, nonvested, weighted average grant date fair value (in dollars per share) 23.70  
Forfeited (in dollars per share) 5.56  
Vested, weighted average grant date fair value (in dollars per share) 5.99  
Nonvested, weighted average grant date fair value, end of period (in dollars per share) $ 11.51  
Stock Appreciation Rights (SARs)    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Total share-based compensation expense $ 0 $ 7
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested, Number of Shares [Roll Forward]    
Number of nonvested shares, beginning of period (in shares) 1,003,250  
Granted, nonvested, number of shares (in shares) 0  
Exercised, number of shares (in shares) (35,260)  
Forfeited, number of shares (in shares) 0  
Expired (in shares) 0  
Number of nonvested shares, end of period (in shares) 967,990  
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]    
Nonvested, weighted average grant date fair value, beginning of period (in dollars per share) $ 6.67  
Granted, nonvested, weighted average grant date fair value (in dollars per share) 0  
Exercised (in dollars per share) 6.47  
Forfeited (in dollars per share) 0  
Expired (in dollars per share) 0  
Nonvested, weighted average grant date fair value, end of period (in dollars per share) $ 6.68  
Number of shares, exercisable (in shares) 967,990  
Exercisable (in dollars per share) $ 6.68  
Weighted Average Remaining Contractual Life (Years) 1 year 18 days  
Intrinsic value, outstanding $ 11,200  
Exercisable, Intrinsic value $ 11,200  
Weighted Average Remaining Contractual Life, Exercisable 1 year 18 days